
Search
Filter Results
Displaying 701–710 of 1070 results
-
Dec 16, 2019
First Patient Receives ProQR’s AON Therapy in Clinical Trial for RP Caused by RHO-P23H Mutation
The trial becomes ProQR’s third human study for inherited retinal disease therapies
-
Giving through your donor-advised fund (DAF) is a powerful way to help the Foundation Fighting Blindness find treatments and cures to blinding retinal diseases.
-
Dec 11, 2019
Families and Scientists Meet to Discuss Therapy Development for People with RDH12 Mutations
Proof-of-concept for RDH12 gene therapy demonstrated in mouse model
-
Coping with a Vision Loss Diagnosis
Being diagnosed with an eye condition that causes partial or complete vision loss is a highly emotional experience. Vision loss may come unexpectedly and be frightening. Newly-diagnosed patients frequently struggle with grief and depression, similar to losing a loved one. When managed using healthy coping methods and strategies, this is a natural and normal response to vision loss.
-
Dec 6, 2019
Offer support to patients with inherited eye diseases
While genetic testing can direct treatment and identify those at risk, it is important to have support available when patients test positive.
-
Dec 6, 2019
Returning the favor: Never too late to give back as a premium surgeon
Whether local or international, through donation of services or funds, there is a way for everyone to give back.
-
National Science Call - 12/4/2019
PowerPoint presentation with audio from the National Science Call, recorded on December 4, 2019
-
Nov 27, 2019
Known as Pro-EYS, the study will help researchers design clinical trials for potential therapies
-
Nov 22, 2019
Dr. Marciello doesn’t let a Stargardt disease diagnosis get in the way of his twin passions: medicine and baseball.
-
Nov 15, 2019
FDA Authorizes Stem Cell Clinical Trial for RP in Los Angeles
Phase 1/2a human study will evaluate neural progenitors for preserving vision